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Viral-mediated oncolysis is a promising cancer therapeutic approach offering an increased 
efficacy with less toxicity than the current therapies. The complexity of solid tumor 
microenvironments includes regions of hypoxia. In these regions, the transcription factor, 
hypoxia inducible factor (HIF), is active and regulates expression of many genes that 
contribute to aggressive malignancy, radio-, and chemo-resistance. To investigate the 
oncolytic efficacy of a highly virulent (velogenic) Newcastle disease virus (NDV) in the 
presence or absence of HIF-2α, renal cell carcinoma (RCC) cell lines with defective or 
reconstituted wild-type (wt) von Hippel-Lindau (VHL) activity were used. We show that 
these RCC cells responded to NDV by producing only interferon (IFN)-β, but not IFN-α, and 
are associated with increased STAT1 phosphorylation. Restoration of wt VHL expression 
enhanced NDV-induced IFN-β production, leading to prolonged STAT1 phosphorylation and 
increased cell death. Hypoxia augmented NDV oncolytic activity regardless of the cells' HIF-
2α levels. These results highlight the potential of oncolytic NDV as a potent therapeutic agent 
in the killing of hypoxic cancer cells. 
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